Raymond James Financial Services Advisors’s AngioDynamics ANGO Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,614	Closed	-$203K	–	3242
2023 Q1	$203K	Sell	19,614 -8,176	-29%	-$105K	﹤0.01%	2906
2022 Q4	$383K	Sell	27,790 -16,665	-37%	-$232K	﹤0.01%	2420
2022 Q3	$910K	Buy	44,455 +3,771	+9%	+$82.8K	﹤0.01%	1866
2022 Q2	$787K	Sell	40,684 -1,455	-3%	-$29.8K	﹤0.01%	1989
2022 Q1	$908K	Buy	42,139 +12,231	+41%	+$278K	﹤0.01%	2021
2021 Q4	$825K	Buy	+29,908	New	+$825K	﹤0.01%	2093

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial Services Advisors's ANGO Position: Q2 2023 in Review

Raymond James Financial Services Advisors sold out of AngioDynamics (ANGO) in Q2 2023, closing a stake of 19,614 shares — an estimated $203K sold.

Raymond James Financial Services Advisors first reported a position in ANGO in Q4 2021 and held it in 6 quarters. The position peaked at $910K in Q3 2022. 156 funds tracked by Wall St. Rank hold ANGO as of Q2 2023.

Raymond James Financial Services Advisors reported no remaining AngioDynamics position as of Q2 2023 after selling out during the quarter.
Raymond James Financial Services Advisors sold 19,614 AngioDynamics shares in Q2 2023, an estimated $203K.
Raymond James Financial Services Advisors first reported a position in AngioDynamics in Q4 2021 and held it in 6 quarters.
Raymond James Financial Services Advisors's AngioDynamics position peaked at $910K in Q3 2022.
156 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2023, filed 25 Jul 2023.